Biologic therapies that modulate IL-13, TSLP, and ILC2 activation may be particularly beneficial in females with severe asthma, whereas targeting ST2L signaling and modifying Let-7 or miR-712 expression may provide novel treatment avenues for males. Here, IL13 is linked to asthma.